Cognitive Behavioral Therapy for Breast Cancer
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on improving adherence to Aromatase Inhibitor medications, so you may need to continue those if you are already taking them.
What data supports the effectiveness of the treatment Cognitive Behavioral Therapy based Pain Management Program for breast cancer?
Research shows that cognitive-behavioral interventions, which include teaching patients strategies to manage pain, are effective in reducing pain and suffering in cancer patients. These interventions help improve patients' ability to manage their pain and may reduce the need for pain medication.12345
Is Cognitive Behavioral Therapy safe for breast cancer patients?
How does Cognitive Behavioral Therapy for Breast Cancer differ from other treatments?
Cognitive Behavioral Therapy (CBT) for breast cancer is unique because it focuses on managing pain through psychological techniques like education, relaxation, and goal setting, rather than relying solely on medications. This approach helps improve mental well-being and coping strategies, which can enhance overall quality of life for patients.178910
What is the purpose of this trial?
The purpose of this research is to evaluate the effectiveness of a multidisciplinary pain management program for AIMSS in reducing pain, subjective cognitive complaints, psychological distress, and impaired functional status resulting in improved adherence to Aromatase Inhibitor medications compared to usual care. We want to identify predictors of improvement in pain, functional status, subjective cognition and mood following participation in the program.
Research Team
Barbara Bruce, Ph.D., LP
Principal Investigator
Mayo Clinic
Eligibility Criteria
This trial is for breast cancer survivors over 18 years old with Stage 0-III hormone receptor-positive (HR+) breast cancer, who have an ECOG performance status of ≤2 and are seeking ways to manage pain and improve quality of life. It's not open to those with Stage IV HR+ breast cancer or under the age of 18.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants in the treatment group will participate in a multicomponent pain management program in addition to standard of care treatment
Follow-up
Participants are monitored for adherence to Aromatase Inhibitors and other outcomes such as pain, cognitive function, and psychological distress
Treatment Details
Interventions
- Cognitive Behavioral Therapy based Pain Management Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor